zepbound novo nordisk - Search News

News

Zepbound beats Wegovy for weight loss

Reuters on MSN · 2d

Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as reducing waist circumference, citing data from a head-to-head trial. The data is the first head-to-head trial comparing the wildly popular medicines,

Quartz on MSN · 2d

Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study

Eli Lilly’s (LLY) and Novo Nordisk’s (NVO) weight loss drugs went head-to-head in a weight loss study for the first time — and Eli Lilly’s drug came out on top.

Is Zepbound or Wegovy better for weight loss? First-of-its-kind study offers answer

The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.

4hon MSN

Novo Nordisk strikes $2.2 billion deal with Septerna to develop new obesity treatments

Novo Nordisk has struck a collaboration and licensing deal with U.S. biotech Septerna to develop oral small molecule ...

1d

Zepbound trims more belly fat than Wegovy, study shows

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

Novo Nordisk and Septerna Team Up for Groundbreaking Obesity Treatments

Novo Nordisk partners with U.S. biotech Septerna in a $2.2 billion deal to develop oral small molecule drugs for obesity and ...

1h

Novo Nordisk Strikes $2.2 Billion Deal To Develop New Obesity Treatments

European pharmaceutical giant Novo Nordisk (NVO) has struck a licensing deal with U.S. biotech firm Septerna (SEPN) to ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results